Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2014, Article ID 796510, 16 pages
Review Article

Alendronate versus Raloxifene for Postmenopausal Women: A Meta-Analysis of Seven Head-to-Head Randomized Controlled Trials

1Department of Orthopaedic Surgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, China
2Department of Orthopaedic Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19014, USA
3Department of Epidemiology and Biostatistics, School of Public Health, Drexel University, Philadelphia, PA 19102, USA

Received 14 May 2013; Accepted 31 October 2013; Published 5 January 2014

Academic Editor: Faustino R. Pérez-López

Copyright © 2014 Tiao Lin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Supplementary Material

Supplementary file 1. Meta-regression analysis of relative risks in the upper gastrointestinal disorders comparison between alendronate and raloxifene [Potential influential factors: A. participants’ age; B: daily (1) or weekly (0) administration of alendronate)]

Supplementary file 2. Trim and filled funnel plots of total fracture risk comparison between alendronate and raloxifene.

  1. Supplementary Files